Saneca Pharmaceuticals a. s.
ActiveKey figures
Key figures
2025Dividends
calculatedDistributed as dividends 3 900 000 € (13 % of distributable profit).
Summary: Saneca Pharmaceuticals a. s.
What kind of company is it?
Saneca Pharmaceuticals a. s. (IČO 46833323) is a joint-stock company (a.s.). The company was incorporated in 2012 and has existed for 14 years. Registered office according to the register: Hlohovec. Main activity according to the Statistical Office: výroba farmaceutických prípravkov (SK NACE 2120). Size category by number of employees: 1,000–1,999 employees.
Who runs the company and who owns it?
The statutory body has 3 members. The supervisory board has 3 members. The registered capital is 14 339 100 €.
How is the company doing financially?
Revenue for 2025 was 108 810 936 €, up 15,2 % on the previous year (94 470 137 €). From 2020 to 2025, revenue grew by an average of 12,1 % per year. This is the highest revenue in the reported years (2020–2025). Net profit for 2025 was 12 080 065 € (11,1 % of revenue). The company was profitable in all 6 reported years. Personnel costs for 2025 were 34 758 556 €. At the end of 2025 the company had total assets of 118 135 266 € and equity of 55 180 084 € (equity ratio 46,7 %).
Where does the data come from and how current is it?
Company and people data come from the Register of Legal Entities (Statistical Office SR, CC BY 4.0) and financial statements from the Register of Financial Statements (Ministry of Finance SR); icoprofil.sk updates them daily. Data as of 21. 11. 2026. Changes, averages and ratios are calculated by icoprofil.sk from open data and are not an official assessment.
Summary of annual reports2020–2025
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Revenue (net turnover) | 61 382 551 | 73 201 930 | 85 943 502 | 94 470 137 | 108 810 936 |
| Profit for the reporting year | 1 411 732 | 1 678 242 | 7 573 259 | 9 904 006 | 12 080 065 |
| Retained earnings of previous periods | 10 570 599 | 12 910 412 | 12 688 654 | 20 074 413 | 25 893 099 |
| Total assets | 71 615 119 | 76 777 917 | 83 899 506 | 91 800 405 | 118 135 266 |
| Total liabilities | 43 338 443 | 45 454 168 | 46 415 877 | 43 131 332 | 59 872 483 |
| Total equity | 26 952 331 | 29 558 654 | 36 169 413 | 47 000 019 | 55 180 084 |
| Calculated dividends | 0 | 0 | 962 500 | 0 | 3 900 000 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
Click a company to see its connections.
The graph is based on entries in the Register of Legal Persons. Shares are calculated from shareholders' contributions; this is not a record of beneficial owners. Individuals are not linked across companies.
Documents in the Register of Financial Statements19
- 2025 Správa audítora
- 2025 Úč POD · 12 pp.
- 2025 Úč POD
- 2024 Oznámenie o dátume schválenia účtovnej závierky · 1 pp.
- 2024 Správa audítora
- 2024 Úč POD · 12 pp.
- 2024 Úč POD
- 2023 Oznámenie o dátume schválenia účtovnej závierky · 1 pp.
- 2023 Správa audítora
- 2023 Úč POD · 12 pp.
- 2023 Úč POD
- 2022 Oznámenie o dátume schválenia účtovnej závierky · 1 pp.
- 2022 Správa audítora
- 2022 Úč POD · 12 pp.
- 2022 Úč POD
- 2021 Oznámenie o dátume schválenia účtovnej závierky · 1 pp.
- 2021 Správa audítora
- 2021 Úč POD · 12 pp.
- 2021 Úč POD
Documents open directly on registeruz.sk (Ministry of Finance of the Slovak Republic).
Similar companies
- MEDE s. r. o. · Lehnice
- BIOMIN, a.s. · Cífer
- Vitalos s. r. o. · Bratislava
- UNIMED PHARMA, spol. s r.o. · Bratislava
- HBM Pharma s.r.o. · Martin
- G.V.Pharma, a.s. · Hlohovec
- Pharmagal, spol. s.r.o. · Nitra
- hameln rds s. r. o. · Modra
- BEL - MIDITECH, s.r.o. · Kráľová pri Senci
- MED-PLANT, s.r.o. · Modra